574 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Not yet recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
4 Recruiting Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
Condition: Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors
Intervention: Drug: Orteronel 300mg BID
5 Recruiting COsegregation of VARiants in the BRCA1/2 Genes
Conditions: Genes, BRCA1;   Genes, BRCA2;   Ovarian Neoplasms;   Breast Neoplasms
Intervention: Genetic: salivary kit
6 Recruiting Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Conditions: Malignant Pleural Effusion;   Lung Cancer;   Mesothelioma;   Breast Cancer;   Ovarian Cancer
Intervention: Biological: AdV-tk + valacyclovir
7 Recruiting Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: Paclitaxel,;   Drug: Bevacizumab;   Drug: Cisplatin;   Drug: Olaparib
8 Unknown  Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
Conditions: Polycystic Ovary Syndrome;   Hirsutism;   Menstrual Irregularity
Interventions: Drug: myo-inositol 1500 gr;   Drug: myo-inositol 2000 gr + folic acid 200 mcg
9 Recruiting PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
Conditions: Ovarian Neoplasms;   Neoplasms, Ovarian;   Ovarian Cancer
Interventions: Drug: Pazopanib;   Drug: Fosbretabulin
10 Recruiting PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor;   Adenocarcinoma of the Colon;   Adenocarcinoma of the Rectum;   Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Benign Teratoma;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Familial Testicular Germ Cell Tumor;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Male Breast Cancer;   Ovarian Immature Teratoma;   Ovarian Mature Teratoma;   Ovarian Monodermal and Highly Specialized Teratoma;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Extragonadal Germ Cell Tumor;   Recurrent Extragonadal Non-seminomatous Germ Cell Tumor;   Recurrent Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Melanoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Rectal Cancer;   Stage III Extragonadal Non-seminomatous Germ Cell Tumor;   Stage III Extragonadal Seminoma;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Ovarian Germ Cell Tumor;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Extragonadal Non-seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Melanoma;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Rectal Cancer;   Testicular Immature Teratoma;   Testicular Mature Teratoma
Interventions: Drug: PD-0332991;   Other: pharmacological study
11 Recruiting Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Doxorubicin hydrochloride liposome
12 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
13 Recruiting STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy;   Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
14 Recruiting Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010
Conditions: Ovarian Cancer;   Endometrium Cancer;   Cervix Cancer
Intervention: Other: gynecological cancer
15 Recruiting A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Low-grade Serous Ovarian Cancer;   Low-grade Serous Fallopian Tube Cancer;   Low-grade Serous Peritoneal Cancer
Interventions: Drug: MEK162, MEK inhibitor; oral;   Drug: Physician's choice chemotherapy
16 Not yet recruiting Liver and Fat Regulation in Overweight Adolescent Girls
Conditions: Hepatic Steatosis;   Polycystic Ovarian Syndrome;   Obesity
Intervention:
17 Recruiting Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.
Conditions: Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:
18 Recruiting A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Condition: Platinum Sensitive Ovarian Cancer
Interventions: Drug: Active comparator: Niraparib;   Drug: placebo
19 Recruiting (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Oxaliplatin
20 Unknown  Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
Conditions: Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Gastrointestinal Complications;   Infertility;   Long-term Effects Secondary to Cancer Therapy in Children;   Neurotoxicity;   Ovarian Cancer;   Pulmonary Complications;   Sexual Dysfunction;   Urinary Complications
Interventions: Procedure: assessment of therapy complications;   Procedure: quality-of-life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years